A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12- to 15-year-olds. by BY APOORVA MANDAVILLI


Published: May 12, 2021 at 09:11PM

from NYT Health https://ift.tt/33B3aS4